drugset / Trial / NCT00651599

Treatment of Vasomotor Symptoms in Korean Post Menopausal Women

NCT00651599

Phase 3 Completed 90 enrolled Bayer
RandomizedParallel-groupTriple-blindTreatment

Summary

Study to demonstrate that the therapeutic efficacy of Angeliq® is better than placebo in Korean postmenopausal women with hot flushes and other climacteric symptoms. Safety and tolerability of Angeliq.

Timeline

Start
2004-07
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject 17ß-estradiol Unknown Oral
Subject drospirenone Unknown Oral

Indications